Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

1.

Considerations for controlling invasive meningococcal disease in high income countries.

Holst J, Nøkleby H, Bettinger JA.

Vaccine. 2012 May 30;30 Suppl 2:B57-62. doi: 10.1016/j.vaccine.2011.12.093. Review.

PMID:
22607900
[PubMed - indexed for MEDLINE]
2.

The changing and dynamic epidemiology of meningococcal disease.

Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, McIntyre P, Ramsay ME, Sáfadi MA.

Vaccine. 2012 May 30;30 Suppl 2:B26-36. doi: 10.1016/j.vaccine.2011.12.032. Epub 2011 Dec 15. Review.

PMID:
22178525
[PubMed - indexed for MEDLINE]
3.

The challenge of post-implementation surveillance for novel meningococcal vaccines.

Snape MD, Medini D, Halperin SA, DeTora L, Drori J, Moxon ER.

Vaccine. 2012 May 30;30 Suppl 2:B67-72. doi: 10.1016/j.vaccine.2011.12.126. Epub 2012 Jan 9. Review.

PMID:
22230578
[PubMed - indexed for MEDLINE]
4.

[Meningococcal vaccines: from polysaccharide to conjugate vaccines].

Cohen R, Levy C.

Arch Pediatr. 2012 Sep;19 Suppl 2:S61-4. doi: 10.1016/S0929-693X(12)71275-7. French.

PMID:
22883368
[PubMed - indexed for MEDLINE]
5.

Meningococcal vaccines: current issues and future strategies.

Cohn AC, Harrison LH.

Drugs. 2013 Jul;73(11):1147-55. doi: 10.1007/s40265-013-0079-2. Review.

PMID:
23839656
[PubMed - indexed for MEDLINE]
6.

Meningococcal vaccine development--from glycoconjugates against MenACWY to proteins against MenB--potential for broad protection against meningococcal disease.

Dull PM, McIntosh ED.

Vaccine. 2012 May 30;30 Suppl 2:B18-25. doi: 10.1016/j.vaccine.2012.01.062. Review.

PMID:
22607895
[PubMed - indexed for MEDLINE]
7.

Prospects for vaccine prevention of meningococcal infection.

Harrison LH.

Clin Microbiol Rev. 2006 Jan;19(1):142-64. Review.

PMID:
16418528
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults.

Pace D.

Future Microbiol. 2010 Nov;5(11):1629-40. doi: 10.2217/fmb.10.137.

PMID:
21133685
[PubMed - indexed for MEDLINE]
9.

Meningococcal disease: a review on available vaccines and vaccines in development.

Bröker M, Fantoni S.

Minerva Med. 2007 Oct;98(5):575-89. Review.

PMID:
18043565
[PubMed - indexed for MEDLINE]
10.

Quadrivalent meningococcal conjugate vaccines.

Pace D, Pollard AJ, Messonier NE.

Vaccine. 2009 Jun 24;27 Suppl 2:B30-41. doi: 10.1016/j.vaccine.2009.05.003. Epub 2009 May 27. Review.

PMID:
19477560
[PubMed - indexed for MEDLINE]
11.

Challenges for development of meningococcal vaccines in infants and children.

Deasy A, Read RC.

Expert Rev Vaccines. 2011 Mar;10(3):335-43. doi: 10.1586/erv.11.3. Review.

PMID:
21434801
[PubMed - indexed for MEDLINE]
12.

Vaccine prevention of meningococcal disease, coming soon?

Morley SL, Pollard AJ.

Vaccine. 2001 Dec 12;20(5-6):666-87. Review.

PMID:
11738731
[PubMed - indexed for MEDLINE]
13.
14.

Meningococcal vaccine evolution.

Bona G, Guidi C.

J Prev Med Hyg. 2012 Sep;53(3):131-5.

PMID:
23362617
[PubMed - indexed for MEDLINE]
15.

Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.

Lingappa JR, Rosenstein N, Zell ER, Shutt KA, Schuchat A, Perkins BA; Active Bacterial Core surveillance (ABCs) team.

Vaccine. 2001 Aug 14;19(31):4566-75.

PMID:
11483285
[PubMed - indexed for MEDLINE]
16.

Meningococcal vaccines.

Rosenstein NE, Fischer M, Tappero JW.

Infect Dis Clin North Am. 2001 Mar;15(1):155-69. Review.

PMID:
11301813
[PubMed - indexed for MEDLINE]
17.

Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.

Sáfadi MA, McIntosh ED.

Expert Rev Vaccines. 2011 Dec;10(12):1717-30. doi: 10.1586/erv.11.159. Review.

PMID:
22085175
[PubMed - indexed for MEDLINE]
18.

Meningococcal disease: the advances and challenges of meningococcal disease prevention.

Yogev R, Tan T.

Hum Vaccin. 2011 Aug;7(8):828-37. doi: 10.4161/hv.7.8.16270. Epub 2011 Aug 1. Review.

PMID:
21832882
[PubMed - indexed for MEDLINE]
Free Article
19.

Young-adult carriers of Neisseria meningitidis in Puglia (Italy): will the pattern of circulating meningococci change following the introduction of meningococcal serogroup C conjugate vaccines?

Germinario C, Tafuri S, Napoli C, Montagna MT, Balducci MT, Fortunato F, Martinelli D, Prato R.

Hum Vaccin. 2010 Dec;6(12):1025-7. Epub 2010 Dec 1.

PMID:
21150271
[PubMed - indexed for MEDLINE]
Free Article
20.

A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.

McVernon J, Nolan T, Richmond P, Reynolds G, Nissen M, Lambert SB, Marshall H, Papa T, Rehm C.

Pediatr Infect Dis J. 2012 Jan;31(1):e15-23. doi: 10.1097/INF.0b013e31823e1e34.

PMID:
22094636
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk